ChemicalBook > CAS DataBase List > GLPG-1690

GLPG-1690

Product Name
GLPG-1690
CAS No.
1628260-79-6
Chemical Name
GLPG-1690
Synonyms
ziritaxestat;GLPG11690;2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile;CS-2644;GLPG-1690;GLPG 1690;GLPG1690;GLPG-1690 USP/EP/BP;Ziritaxestat (GLPG-1690);GLPG-1690; GLPG 1690; GLPG1690; ZIRITAXESTAT.;2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl](methyl)amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile
CBNumber
CB93152899
Molecular Formula
C30H33FN8O2S
Formula Weight
588.7
MOL File
1628260-79-6.mol
More
Less

GLPG-1690 Property

Density 
1.42±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:70.84(Max Conc. mg/mL);120.32(Max Conc. mM)
Ethanol:4.0(Max Conc. mg/mL);6.79(Max Conc. mM)
form 
A crystalline solid
pka
13.72±0.20(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
25498
Product name
GLPG1690
Purity
≥98%
Packaging
5mg
Price
$93
Updated
2024/03/01
Cayman Chemical
Product number
25498
Product name
GLPG1690
Purity
≥98%
Packaging
10mg
Price
$166
Updated
2024/03/01
Cayman Chemical
Product number
25498
Product name
GLPG1690
Purity
≥98%
Packaging
25mg
Price
$343
Updated
2024/03/01
Cayman Chemical
Product number
25498
Product name
GLPG1690
Purity
≥98%
Packaging
50mg
Price
$593
Updated
2024/03/01
TRC
Product number
G411813
Product name
GLPG1690
Packaging
25mg
Price
$310
Updated
2021/12/16
More
Less

GLPG-1690 Chemical Properties,Usage,Production

Uses

GLPG1690 is a selective autotaxin inhibitor discovered by Galapagos, with potential application in idiopathic pulmonary disease (IPF). In a Phase 1 study in healthy human volunteers, GLPG1690 demonstrated favorable safety and tolerability, as well as a strong pharmacodynamic signal implying target engagement.

GLPG-1690 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less
More
Less

View Lastest Price from GLPG-1690 manufacturers

Dideu Industries Group Limited
Product
GLPG-1690 1628260-79-6
Price
US $1.10/g
Min. Order
1g
Purity
99.9%
Supply Ability
100 Tons min
Release date
2021-08-18

1628260-79-6, GLPG-1690Related Search:


  • GLPG-1690
  • 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile
  • CS-2644
  • GLPG 1690;GLPG1690
  • GLPG-1690; GLPG 1690; GLPG1690; ZIRITAXESTAT.
  • ziritaxestat
  • 5-Thiazolecarbonitrile, 2-[[2-ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)-
  • GLPG11690
  • GLPG-1690 USP/EP/BP
  • Ziritaxestat (GLPG-1690)
  • 2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl](methyl)amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile
  • 1628260-79-6
  • C30H33FN8O2S
  • APIS
  • API